CSS LLC’s Apellis Pharmaceuticals APLS Stock Holding History

CSS LLC’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42,818	Closed	-$1.72M	–	1014
2026 Q1	$1.72M	Buy	+42,818	New	+$923K	0.08%	185
2022 Q2	–	Sell	-1,446	Closed	-$73K	–	1098
2022 Q1	$73K	Buy	+1,446	New	+$63.8K	﹤0.01%	973

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CSS LLC's APLS Position: Q2 2026 in Review

CSS LLC sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 42,818 shares — an estimated $1.72M sold.

CSS LLC first reported a position in APLS in Q1 2022 and held it in 2 quarters. The position peaked at $1.72M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

CSS LLC reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
CSS LLC sold 42,818 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.72M.
CSS LLC first reported a position in Apellis Pharmaceuticals in Q1 2022 and held it in 2 quarters.
CSS LLC's Apellis Pharmaceuticals position peaked at $1.72M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.